PRAZIQUANTEL Drug Patent Profile
✉ Email this page to a colleague
When do Praziquantel patents expire, and when can generic versions of Praziquantel launch?
Praziquantel is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in PRAZIQUANTEL is praziquantel. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the praziquantel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Praziquantel
A generic version of PRAZIQUANTEL was approved as praziquantel by ENDO OPERATIONS on November 27th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRAZIQUANTEL?
- What are the global sales for PRAZIQUANTEL?
- What is Average Wholesale Price for PRAZIQUANTEL?
Summary for PRAZIQUANTEL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 146 |
| Clinical Trials: | 51 |
| Patent Applications: | 3,210 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PRAZIQUANTEL |
| DailyMed Link: | PRAZIQUANTEL at DailyMed |
Recent Clinical Trials for PRAZIQUANTEL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kintampo Health Research Centre, Ghana | N/A |
| London School of Hygiene and Tropical Medicine | N/A |
| Université de Thies, UFR Santé, Senegal | N/A |
Pharmacology for PRAZIQUANTEL
| Drug Class | Anthelmintic |
Medical Subject Heading (MeSH) Categories for PRAZIQUANTEL
Anatomical Therapeutic Chemical (ATC) Classes for PRAZIQUANTEL
US Patents and Regulatory Information for PRAZIQUANTEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | PRAZIQUANTEL | praziquantel | TABLET;ORAL | 208820-001 | Nov 27, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
